| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Research Institute for Biological Sciences, Tokyo University of Science, Chiba, Japan; and
Kirin Brewery Company, Yokohama, Japan
Src homology protein 1 (SHP-1) plays an important role in B cell Ag receptor (BCR) differentiation, proliferation, survival, and apoptosis. After BCR stimulation in apoptotic cells, SHP-1 has been shown to be recruited to phosphorylated immunoreceptor tyrosine-based inhibitory motifs present in receptors such as CD22 and CD72. However, the substrates of SHP-1 in the chicken B cell line, DT40, have remained undefined. To identify SHP-1 substrates in DT40, we used a trapping mutant, SHP-1 C/S (a catalytically inactive form). Cross-linking of BCR induced hyperphosphorylation of 
44-kDa protein in C/S transfectants. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis revealed that this was actin (cytoplasmic type 5) carrying three immunoreceptor tyrosine-based inhibitory motif-like sequences. SHP-1 was shown to bind to one of these sequences in synthetic peptide binding experiment. Thus, actin is a direct SHP-1 substrate. Furthermore, more SHP-1 molecules translocate into lipid rafts, and their association with actin was increased after BCR stimulation. In C/S transfectants, actin polymerization induced by membrane IgM ligation was sustained to a greater extent for a longer time compared with wild-type transfectants. Therefore, actin dephosphorylation by SHP-1 is essential for actin depolymerization after BCR stimulation. Our data suggest that SHP-1 plays a pivotal role in reorganization of cytoskeletal architecture inducing actin dephosphorylation. These results clearly demonstrate the direct interaction of SHP-1 with actin.
This article has been cited by other articles:
|
|
 |
|
  N. Gertzberg, T. Gurnani, P. Neumann, A.-K. Forbes, N. Jean-Louis, and A. Johnson Tumor necrosis factor-{alpha} causes barrier dysfunction mediated by tyrosine198 and tyrosine218 in beta-actin Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1219 - L1229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Sathish, G. Dolton, F. G. LeRoy, and R. J. Matthews Loss of Src Homology Region 2 Domain-Containing Protein Tyrosine Phosphatase-1 Increases CD8+ T Cell-APC Conjugate Formation and Is Associated with Enhanced In Vivo CTL Function J. Immunol., January 1, 2007; 178(1): 330 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Neumann, N. Gertzberg, E. Vaughan, J. Weisbrot, R. Woodburn, W. Lambert, and A. Johnson Peroxynitrite mediates TNF-{alpha}-induced endothelial barrier dysfunction and nitration of actin Am J Physiol Lung Cell Mol Physiol, April 1, 2006; 290(4): L674 - L684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. F. Bairstow, K. Ling, and R. A. Anderson Phosphatidylinositol Phosphate Kinase Type I{gamma} Directly Associates with and Regulates Shp-1 Tyrosine Phosphatase J. Biol. Chem., June 24, 2005; 280(25): 23884 - 23891. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-P. Lim, C. Y. Wong, L. L. Ooi, B. J. Druker, and R. J. Epstein Selective Tyrosine Hyperphosphorylation of Cytoskeletal and Stress Proteins in Primary Human Breast Cancers: Implications for Adjuvant Use of Kinase-Inhibitory Drugs Clin. Cancer Res., June 15, 2004; 10(12): 3980 - 3987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-P. Lim, L.-S. Diong, R. Qi, B. J. Druker, and R. J. Epstein Phosphoproteomic fingerprinting of epidermal growth factor signaling and anticancer drug action in human tumor cells Mol. Cancer Ther., December 1, 2003; 2(12): 1369 - 1377. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
